These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30344938)

  • 1. Clearance of HBeAg and HBsAg of HBV in mice model by a recombinant HBV vaccine combined with GM-CSF and IFN-α as an effective therapeutic vaccine adjuvant.
    Zhao W; Zhao G; Zhang S; Wang X; Yu X; Wang B
    Oncotarget; 2018 Sep; 9(76):34213-34228. PubMed ID: 30344938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of Ly6C
    Zhao W; Zhou X; Zhao G; Lin Q; Wang X; Yu X; Wang B
    Hum Vaccin Immunother; 2017 Dec; 13(12):2872-2882. PubMed ID: 28699816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study on the combined therapy of granulocyte-macrophage colony-stimulating factor and hepatitis B vaccine on chronic hepatitis B virus carrier children.
    Wang J; Zhu Q; Zhang T; Yu H
    Chin Med J (Engl); 2002 Dec; 115(12):1824-8. PubMed ID: 12622932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells.
    Chou HY; Lin XZ; Pan WY; Wu PY; Chang CM; Lin TY; Shen HH; Tao MH
    J Immunol; 2010 Nov; 185(9):5468-75. PubMed ID: 20889541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antivirus effect of plasmid co expressing hepatitis B surface antigen and granulocyte macrophage-colony stimulating factor].
    Qing YL; Zhao JJ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):201-4. PubMed ID: 15099465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of an HBV DNA vaccine by fusion of the GM-CSF gene to the HBV-S gene and examination of its immune effects in normal and HBV-transgenic mice.
    Qing Y; Chen M; Zhao J; Hu H; Xu H; Ling N; Peng M; Ren H
    Vaccine; 2010 Jun; 28(26):4301-7. PubMed ID: 20430121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
    Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
    World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
    Yeh ML; Peng CY; Dai CY; Lai HC; Huang CF; Hsieh MY; Huang JF; Chen SC; Lin ZY; Yu ML; Chuang WL
    PLoS One; 2015; 10(4):e0122259. PubMed ID: 25835020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
    Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
    Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mafosfamide Boosts GMI-HBVac against HBV via Treg Depletion in HBV-Infected Mice.
    Lin Q; Zhong Y; Wang B
    Vaccines (Basel); 2023 May; 11(6):. PubMed ID: 37376415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
    Sonneveld MJ; Rijckborst V; Cakaloglu Y; Simon K; Heathcote EJ; Tabak F; Mach T; Boucher CA; Hansen BE; Zeuzem S; Janssen HL
    Antivir Ther; 2012; 17(1):9-17. PubMed ID: 22267464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
    Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
    Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical research on the treatment effect of autologous dendritic cell vaccine on the patients with chronic hepatitis B].
    Li YG; Chen M; Zhang DZ; Wang ZY; Zeng WQ; Shi XF; Guo Y; Guo SH; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):206-8. PubMed ID: 12716515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
    Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
    Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-macrophage colony-stimulating factor, a potent adjuvant for polarization to Th-17 pattern: an experience on HIV-1 vaccine model.
    Mahdavi M; Tajik AH; Ebtekar M; Rahimi R; Adibzadeh MM; Moozarmpour HR; Beikverdi MS; Olfat S; Hassan ZM; Choopani M; Kameli M; Hartoonian C
    APMIS; 2017 Jun; 125(6):596-603. PubMed ID: 28493367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.